Development of an anti-human complement C6 monoclonal antibody that inhibits the assembly of membrane attack complexes

Membrane attack complexes (MACs; C5b-9) assembled after complement activation can directly injure self-tissues, leading to various diseases. Eculizumab, a monoclonal antibody (mAb) against complement component C5, is being used in the clinic to treat diseases in which MAC-mediated tissue damage is a...

Cijeli opis

Spremljeno u:
Bibliografski detalji
Izdano u:Blood Adv
Glavni autori: Lin, Kimberly, Zhang, Lingjun, Kong, Michael, Yang, Maojing, Chen, Yinghua, Poptic, Earl, Hoffner, Melanie, Xu, Jijun, Tam, Connie, Lin, Feng
Format: Artigo
Jezik:Inglês
Izdano: American Society of Hematology 2020
Teme:
Red Cells, Iron, and Erythropoiesis
Online pristup:https://ncbi.nlm.nih.gov/pmc/articles/PMC7218433/
https://ncbi.nlm.nih.gov/pubmed/32396613
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/bloodadvances.2020001690
Oznake: Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!

Similar Items